Warby Parker Inc. (WRBY) exhibits 54.0% gross margins and -1.7% return on invested capital within Health Care (Ophthalmic Goods), balanced against a 185.0x enterprise multiple and 7.4% implied options volatility.
Sustained 54.0% gross profitability converts into -0.6% operating margin and -1.7% ROIC, outpacing sector cost of capital.
ROIC: -1.7% // GM: 54.0%YoY revenue trajectory of +13.0% paired with 1.44% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +13.0% // FCF YLD: 1.44%Altman Z-Score of 5.35 and Piotroski F-Score of 9/9 indicate low near-term refinancing stress.
ALTMAN Z: 5.35 // F-SCORE: 9/9Trading at 185.0x trailing P/E (140.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 185.0x // EV/EBITDA: —Options market prices a ±7.4% implied move with a 0.76 put/call ratio around $24.00 max pain.
IMPL MOVE: ±7.4% // P/C: 0.76Elevated industry capital intensity and customer concentration in Ophthalmic Goods require continuous execution to defend 0.2% net margins.
NET MARGIN: 0.2% // D/E: 0.40x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for WRBY & activate live FRED threshold breach alerts.